Is NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.0% / 30% | 0.0% / 30% | 0.0% / 30% | 19.44% / 5% | ✗ NOT HALAL |
| DJIM | 0.0% / 33% | 0.0% / 33% | 0.0% / 33% | 19.44% / 5% | ✗ NOT HALAL |
| MSCI | 0.7% / 33% | 1.9% / 33% | 0.0% / 33% | 19.44% / 5% | ✗ NOT HALAL |
| S&P | 0.0% / 33% | 0.0% / 33% | 0.0% / 33% | 19.44% / 5% | ✗ NOT HALAL |
| FTSE | 0.7% / 33% | 1.9% / 33% | 0.0% / 50% | 19.44% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 100.0% | |
| Operating Margin | -77706.3% | |
| Net Margin | 0.0% | |
| Return on Assets (ROA) | -853.6% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$4M |
| Free Cash Flow | -$4M |
| Total Debt | $24,722 |
| Current Ratio | 0.2 |
| Total Assets | $3M |
Price & Trading
| Last Close | $7.28 |
| 50-Day MA | $9.12 |
| 200-Day MA | $8.16 |
| Avg Volume | 54K |
|
52-Week Range
$3.20
| |
About NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), NEONC TECHNOLOGIES HOLDINGS, INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is NEONC TECHNOLOGIES HOLDINGS, INC.'s debt ratio?
NEONC TECHNOLOGIES HOLDINGS, INC.'s debt ratio is 0.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.7%.
What are NEONC TECHNOLOGIES HOLDINGS, INC.'s key financial metrics?
NEONC TECHNOLOGIES HOLDINGS, INC. has a market capitalization of $178M, and revenue of $83,000.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.